Last updated on August 2016

A Study of Mitoxantrone Hydrochloride Liposome Infusion


Brief description of study

This is a Phase 1/2, open-label, multicenter study.

Detailed Study Description

The Phase 1 part of this study is designed to identify the MTD and RP2D, and to characterize the safety, tolerability, and PK. The Phase 1 part of the study will include 2 parts: dose escalation and dose expansion. After confirmation of the RP2D in the expansion part of Phase 1, enrolment into the Phase 2 part of the study will begin. The primary objective of the Phase 2 part of the study is to evaluate the efficacy of the investigational drug when administered to patients with relapsed or refractory NHL.

Clinical Study Identifier: NCT02856685

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Nashat Y Gabrail, MD

Gabrail Cancer Center Research
Canton, OH United States
  Connect »